
@UChicagoMed Comprehensive Cancer Center designated by @theNCI for 50+ yrs. #NothingWillStopUs #WeAreNCIDesignated https://nitter.cf/t.co/RDULLZ8a8j
Chicago, IL
Joined June 2010
- Tweets15.4K
- Following1.6K
- Followers10.2K
- Likes9.3K
November is #LungCancerAwarenessMonth!
A multimodal AI model can now predict immunotherapy outcomes for advanced NSCLC better than standard biomarkers. This landmark international study of 2,396 patients offers major new hope for lung cancer. #AIinCancer
ow.ly/pG5E5107p7i
UChicago Medicine Comprehensive Cancer Center retweeted
Promising Phase II findings! @eevokes of @UCCancerCenter highlights petosemtamabmonotherapy in previously treated R/M HNSCC, achieving a 36% ORR, median PFS of 4.9 months, and median OS of 11.4 months at the 1500 mg dose. #DAVAHeadAndNeck
UChicago Medicine Comprehensive Cancer Center retweeted
Replying to @Sofia_WViana
UChicago Medicine Comprehensive Cancer Center retweeted
Dr. @ajuloorimd discussing challenging cases of thymic tumors at #ITMIG26 with giants in the field Dr. Loehrer, Dr. Detterbeck and Dr. Arrossi. @UCCancerCenter @UChicagoHemOnc
UChicago Medicine Comprehensive Cancer Center retweeted
I was honored to be the Keynote speaker at this amazing Summit. Kudos to the GynOnc team @UCCancerCenter for putting on a phenomenal meeting!
🩸Looking ahead to #ASH2026!
Dr. Benjamin Derman shares his top myeloma abstracts to watch, featuring exciting updates from MajesTEC-5, ASCO living guidelines, and MRD dynamics.
@bdermanmd #MultipleMyeloma
Check out the full breakdown on @oncodaily: ow.ly/2iIB5107mpA
Every three minutes, someone is diagnosed with #lungcancer. But today, the outlook is better than ever, thanks in part to clinical trials that provide patients with the newest targeted treatments, including immunotherapy. 🫁 #LungCancerAwareness #lcsm uchicagomedicine.org/cancer/…
In a new study, @UChicago researchers found that among low-income women on Medicaid with breast cancer, nominal prescription co-payments had no significant impact on whether patients kept up with their vital endocrine therapy medications. @UChicagoPHS
pmc.ncbi.nlm.nih.gov/article…
TODAY at noon!
Join Dr. John R. Prensner for the @UCCancerCenter Seminar Series as he presents “Mapping the Functional Cancer Dark Proteome.” #PediatricCancers #BrainTumors #DarkProtein
@UMich @UChicagoMed @umichmedicine
2
190
UChicago Medicine Comprehensive Cancer Center retweeted
Dr Thirman will be presenting data on transfusion dependence on pts with R/R NPM1m AML treated with revumenib at @ASH_hematology 2026! onlineprogram.hematology.org…
He is also senior author on an abstract looking at menin co-inhibition approaches onlineprogram.hematology.org…
Meet Dr. Akash Patnaik, a medical oncologist & physician-scientist treating prostate, bladder, kidney & testicular cancers. He builds personalized patient cancer models to test new therapies and find biomarkers.
@AkashPatnaik7 @UChicagoMed @UChicagoHemOnc
ow.ly/fZFi5106ug5
November is #LungCancerAwarenessMonth!
Lung cancer may not cause symptoms.
Know the signs: Persistent cough, chest pain, difficulty breathing, coughing up blood, unexplained weight loss, and fatigue. Talk with your doctor about symptoms and
personal risk.
ow.ly/Bko45106ewh
UChicago Medicine Comprehensive Cancer Center retweeted
This Cancer Biomarker Awareness Day, explore OCRA’s free videos about the growing role of biomarkers in gynecologic cancer care, including a new webinar with Sarah Ackroyd, MD, MPH, of University of Chicago Medicine: bit.ly/4k7ZQGF
#CancerBiomarkerAwarenessDay @UChicagoMed

ALT Image of Sarah Ackroyd, MD, MPH. At the bottom is a quote box with copy that reads: "With the evolving field, I think it's always important when you're making treatment decisions to ask about how biomarkers can help guide treatments in your particular care." =Sarah Ackroyd, MD, MPH, University of Chicago Medicine
Final results from the NRG-BR002 trial provide important evidence against routinely adding metastasis-directed treatment in patients with oligometastatic breast cancer when systemic therapy is controlling the disease. @Docace911 @NRGonc
ow.ly/XKpv5105Uwv
UChicago Medicine Comprehensive Cancer Center retweeted
Sharing our ASO @AnnSurgOncol author reflections #jelaniwilliamsmd @JBMatthews @UCCancerCenter @uchicagosurgery #hipec #ethics
UChicago Medicine Comprehensive Cancer Center retweeted
new @BrJHaem article led by @Anand_88_Patel and featuring several leukemia team members looking at venetoclax-based therapies for R/R T-ALL!
@CanerSaygin @emdworkin @DrWendyStock
onlinelibrary.wiley.com/doi/…
UChicago Medicine Comprehensive Cancer Center retweeted
After decades of declining incidence rates, new data shows that colorectal cancer rates are rising for the first time among all age groups - not just in young people. Read our full story: uchicagomedicine.org/forefro…
UChicago Medicine Comprehensive Cancer Center retweeted
A UChicago Medicine clinical trial gave Naperville mom Kerrie Watson access to a promising new pancreatic cancer drug. For Pancreatic Cancer Awareness Month, read Kerrie's story and learn what this treatment could mean for the future of care. uchicagomedicine.org/forefro…
Researchers at @MassGeneralNews and @UChicago are studying how to improve access to lung cancer screening among Black individuals. What they learn could help expand eligibility requirements so that more people can get screened. Learn more: ow.ly/jUcV5105Pna #lcsm #LCAM 🫁
A recent @NEJMEvidence study reports rising colorectal cancer rates not only in younger population but also in older age groups, cautioning a heavy burden on the healthcare system for cancer treatment and survivorship care. #CancerScreening #CancerRisks
ow.ly/vyC15105Plh




























